When you lose weight on a GLP-1 medication, not all of that weight is fat. Depending on how you manage your diet and exercise during treatment, anywhere from 25-40% of the weight you lose may come from lean mass—primarily muscle, along with some bone, water, and organ tissue. This is one of the most important and underappreciated aspects of GLP-1 therapy.
The Numbers: How Much Muscle Are We Talking About?
In the landmark STEP trials, participants on semaglutide who lost about 15% of their body weight lost roughly 55-70% of that weight as fat and 30-45% as lean mass. For a person weighing 250 pounds who loses 37.5 pounds (15%), that could mean losing 11-17 pounds of lean tissue.
This isn’t unique to GLP-1 medications—any rapid weight loss from any method (dieting, surgery, other medications) results in some lean mass loss. The issue is that GLP-1-induced appetite suppression is so effective that patients often eat far less protein than they need, accelerating the problem.
| Metric | Semaglutide Alone | Semaglutide + Bimagrumab |
|---|---|---|
| Total weight loss | 15.7% | 22.1% |
| Weight lost as fat | 55-70% | 92.8% |
| Lean mass lost | 7.9% | 2.6% |
| Visceral fat reduction | 36% | 58% |
Data from the BELIEVE trial (Phase 2b), presented at ADA Scientific Sessions 2025.
Why Muscle Loss Matters
Losing muscle isn’t just an aesthetic concern. It has real health consequences:
- Metabolic slowdown: Muscle is metabolically active tissue. Every pound of muscle lost reduces your resting metabolic rate, making it harder to maintain weight loss and easier to regain.
- Functional decline: Reduced muscle mass affects strength, balance, and physical capability. For older adults, this can accelerate sarcopenia and increase fall risk.
- Body composition quality: You can weigh less but still have a high body fat percentage—a condition sometimes called “skinny fat.” The goal should be improved body composition, not just a lower number on the scale.
- Bone density: Rapid weight loss is associated with decreased bone mineral density. Resistance training helps counteract this by stimulating bone remodeling.
The BELIEVE Trial: A Glimpse of the Future
The most exciting development in muscle preservation came from the Phase 2b BELIEVE trial, presented at the ADA Scientific Sessions in June 2025. The trial tested bimagrumab (a myostatin pathway inhibitor acquired by Eli Lilly for up to $1.9 billion) combined with semaglutide.
The results were remarkable: 92.8% of weight lost came from fat mass rather than the typical 55-70%. Lean mass loss was reduced by 67% compared to semaglutide alone. Patients also achieved greater total weight loss (22.1% vs. 15.7%) and substantially more visceral fat reduction (58% vs. 36%).
A tirzepatide + bimagrumab trial is now underway. If approved, this combination could fundamentally change the body composition outcomes of GLP-1 therapy.
Until Bimagrumab Is Available
Bimagrumab is still in clinical trials and not yet FDA-approved. In the meantime, the strategies below are your best tools for preserving lean mass during GLP-1 therapy. They’re not as powerful as a pharmaceutical myostatin inhibitor, but they’re effective and available right now.
How to Preserve Muscle: Evidence-Based Strategies
1. Protein: The Non-Negotiable Foundation
Protein intake is the single most controllable factor in muscle preservation during weight loss. Current guidelines for patients on GLP-1 medications recommend 1.0-1.2 grams of protein per kilogram of goal body weight per day, with some experts recommending up to 1.6 g/kg for active individuals.
For a person targeting 180 pounds (about 82 kg), that’s 82-130 grams of protein daily. Spread this across meals—the body can only effectively use about 25-40 grams per meal for muscle protein synthesis. A protein supplement (whey, casein, or plant-based) can help when appetite suppression makes eating enough whole food protein difficult.
2. Resistance Training: 2-3 Sessions Per Week Minimum
Resistance training provides the mechanical stimulus muscles need to resist breakdown during a caloric deficit. This doesn’t need to be complicated. Focus on compound movements (squats, deadlifts, presses, rows, pull-ups) that work multiple large muscle groups. Progressive overload—gradually increasing weight, reps, or difficulty—is the key principle.
If you’re new to resistance training, even bodyweight exercises or resistance bands provide meaningful stimulus. The barrier to entry is lower than most people think.
3. Creatine Monohydrate
Creatine is one of the most studied and evidence-supported supplements for muscle preservation. A daily dose of 3-5 grams can support muscle hydration, strength, and recovery. It’s safe, inexpensive, and has decades of research behind it. There’s no loading phase required—just daily consistent use.
4. Don’t Overdo the Caloric Deficit
The appetite suppression from GLP-1 medications can make it easy to eat far too little. While this accelerates weight loss, extreme caloric restriction (below 1,200 calories for women or 1,500 for men) dramatically accelerates muscle loss. Aim for a moderate deficit—500-750 calories below maintenance—rather than the maximum deficit the medication allows.
5. Prioritize Sleep
Growth hormone, which plays a critical role in muscle repair and preservation, is primarily released during deep sleep. Poor sleep quality directly impairs muscle protein synthesis. Aim for 7-9 hours of quality sleep per night.
Supplements Worth Considering
- HMB (beta-hydroxy beta-methylbutyrate): A leucine metabolite that may help reduce muscle protein breakdown during caloric restriction. Typical dose: 3g/day.
- Vitamin D: Deficiency (common in obesity) is associated with muscle weakness and accelerated sarcopenia. Test your levels and supplement if needed.
- Collagen peptides: While not a complete protein, collagen supplementation may support connective tissue health during rapid body changes.
- Electrolytes: Reduced food intake often means reduced electrolyte intake. Supplementing sodium, potassium, and magnesium can support muscle function and prevent cramping.
The Bottom Line
Some lean mass loss during GLP-1 therapy is physiologically inevitable. But with adequate protein, consistent resistance training, and smart supplementation, you can significantly shift the ratio toward fat loss. The goal isn’t just to weigh less—it’s to be leaner, stronger, and more metabolically healthy at your new weight.
Sources
- BELIEVE trial. Bimagrumab + semaglutide Phase 2b results. ADA Scientific Sessions, June 2025.
- STEP 1: Wilding JPH, et al. N Engl J Med. 2021;384:989-1002. Body composition substudy data.
- Mechanick JI, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures. Obesity. 2013.
- Antonio J, et al. International Society of Sports Nutrition position stand: protein and exercise. JISSN. 2017.